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Abstract.  Previous studies on glucocorticoid receptors 
have suggested the existence of interactions between 
the receptor and microtubule or actin networks. It was 
hypothesized that such interactions may contribute to 
the guidance of steroid hormone receptors towards the 
nucleus. 
We used a permanent  L cell line expressing the 
A638-642 progesterone receptor.  This mutant has all 
the characteristics of the wild type receptor except that 
the deletion of five amino acids inactivates the consti- 
tutive karyophilic signal.  Consequently, the receptor is 
cytoplasmic in the absence of hormone but is shifted 
into the nucleus when administration  of hormone acti- 
vates the second karyophilic signal.  Optical micros- 
copy and confocal laser microscopy were used in in- 
tact cells or in cells depleted of soluble elements by 
permeabilization with detergents.  By immunofluores- 
cence, the receptor was found to be mainly concen- 
trated in the perinuclear area.  A  small fraction of 
progesterone receptor (PR) persisted in this region af- 
ter Triton X100 treatment.  These observations sug- 
gested that the receptor could interact with some in- 
soluble constituent(s) of the cytoplasm. However, 
careful colocalization studies showed that this heter- 
ogenous distribution was not due to interactions  with 
microtubule, microfilament,  or intermediate filament 
networks. 
Functional involvement of these networks in the 
translocation of the receptor into the nucleus was 
studied after cell treatment with cytoskeletal drugs 
such as nocodazole, demecolcine and cytochalasin. 
None of these compounds prevented or even delayed 
the hormone-dependent transfer of A638-642 PR into 
the nucleus.  Similar conclusions were reached with 
the wild type receptor expressed by transfection in 
Cos-7 cells. PR was shifted from the nucleus into the 
cytoplasm by administration  of energy-depleting drugs. 
After disruption of the various cytoskeletal networks 
normal nuclear reaccumulation of the receptor was ob- 
served when these drugs were removed. 
The results thus suggest that the progesterone recep- 
tor is not colocalized with the main cytoskeletal com- 
ponents.  Disruption of the cytoskeletal networks does 
not prevent its nuclear translocation.  Thus,  karyophilic 
signals and interactions  with the nuclear pore seem to 
be the primary determinants of the cellular traffic of 
the progesterone receptor. 
T 
HE  progesterone  receptor  (PR) 1 is  an  intracellular 
protein which upon binding  to the hormone,  inter- 
acts with enhancer-like  elements involved in the regu- 
lation of gene transcription  (3).  From cell homogenization 
and fractionation  studies, the cellular localization  of PR and 
other steroid hormone receptors was initially thought to be 
cytoplasmic in the absence of hormone and nuclear in its 
presence  (12,  17). However,  enucleation experiments  and 
immunohistochemical  studies  with mAbs against  estrogen 
and progesterone receptors (ER and PR) have revealed that 
receptor molecules are exclusively  located in the nucleus, 
whether they are hormone-free or -occupied (19, 29, 43). 
The same phenomenon was observed with most steroid re- 
1. Abbreviations used in this paper: GR, glucocorticoid receptor; hsp, heat 
shock protein; NLS, nuclear localization signal; PR, progesterone receptor. 
ceptors, including androgen receptors (15). By contrast, the 
glucocorticoid (11, 44) and mineralocorticoid (9, 25) recep- 
tors seem to be either cytoplasmic or both cytoplasmic and 
nuclear in the absence of hormone, and to accumulate in the 
nucleus  in its presence (11). 
The  mechanisms  of the  nuclear  localization  of steroid 
receptors have begun to be analyzed in recent years (13, 31, 
32). Karyophilic signals involved in the nuclear translocation 
of PR have been characterized  using in vitro mutagenesis of 
receptor cDNA (13). One signal,  constitutively  active and 
present in the hinge region of the receptor, was similar to the 
karyophilic  signal of SV-40 large T antigen  (18, 22). After 
deletion of this karyophilic signal, a second nuclear localiza- 
tion  signal  (NLS) was found to reside in the second zinc 
finger region and to be activated by binding to the hormone 
(13).  Recently,  analysis  of the  subcellular distribution  of 
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cell fusion experiments have provided evidence for a nucleo- 
cytoplasmic shuttle of the PR (14). As a consequence, the 
"nuclear" location of wild-type PR reflects a dynamic equi- 
librium between active nuclear import and outward diffu- 
sion.  However, the mechanisms  of receptor  translocation 
across the nuclear envelope and those of its traffic within the 
cytoplasm,  remain to be elucidated. 
Hypotheses have been made that steroid receptor displace- 
ment toward and within the nucleus involves a protein trans- 
fer system. It has recently been suggested that the transfer 
of glucocorticoid receptors  (GR) into the nucleus may in- 
volve translocation  along  cytoskeletal  scaffolds (33). Im- 
munofluorescent studies have revealed an association of  both 
GR and receptor-associated heat shock protein (hsp90) with 
microtubules (2, 36). Other biochemical (27) and immuno- 
fluorescent (20) studies have reported the association of GR 
with microfilaments, via its interaction with hsp 90. No simi- 
lar  study has been performed  for other steroid receptors. 
Moreover, the question of whether such a colocalization of 
GR with cytoskeletal networks indicates an active participa- 
tion of the cytoskeleton  in guiding the receptor  to the nu- 
cleus, has never been investigated. 
The present study was initiated in order to determine:  (a) 
if PR interacts with elements of the cytoskeleton before its 
transfer into the nucleus; and (b) if an intact cytoskeleton is 
required for receptor translocation.  Taking into account that 
PR mainly resides in the nucleus,  whether or not the hor- 
mone is present (29), we have used a PR mutant (A638-642) 
with five amino-acids deleted from part of the constitutive 
nuclear localization signal. This mutant accumulates in the 
cytoplasm in the absence of hormone and migrates into the 
nucleus in its presence. Since all the functional properties of 
this mutated receptor are preserved,  except for nuclear ac- 
cumulation in the absence of  hormone (13, 14), we hoped to 
observe  functional  interactions  with  cytoplasmic  compo- 
nents. We have, therefore, compared the distribution by im- 
munofluorescence of this mutated form of PR with those of 
various elements of the cytoskeleton.  Moreover, the hor- 
mone-dependent nuclear translocation of the mutant PR in 
cells treated by cytoskeleton  disrupting  drugs  was investi- 
gated. Similar experiments were also performed with wild- 
type PR after its  shift into the  cytoplasm  under energy- 
depleted conditions (14). Results show that the PR labeling 
pattern is not similar to that of any of the three cytoskeletal 
networks and that the translocation of PR into the nucleus 
is not affected by disruption  of any of these networks. 
Materials and Methods 
Cell Culture 
Mouse L cells  (NCTC 929) (fibroblast-like  cells,  derived  from subcutane- 
ous  areolar  and  adipose  tissue)  were used as  the  recipient  cell  for  the  study 
of  PR expression.  A cell  line  permanently expressing  a A638--642 mutant 
of  the  PR was established  as  described  elsewhere  (14).  This mutant can be 
shifted into  the nucleus by administration  of hormone.  Progesterone  or 
agonist  R5020 (I0  -6 M) in culture  medium was used for 4 h where indi- 
cated.  These cells  were subcultured  as monolayers at  weekly splits  of 1:6 
in a DME.  DME was supplemented with 10% stripped FCS (treated by 
dextran-coated charcoal and ~yzed).  Cell culture was performed in a 
moist chamber atmosphere of 5% CO2 and 95% air at +37~  The cells 
were platexi on "Chamber slides"  (Nunc Inc., Roskilde,  Denmark), each 
well (18  ￿  18 mm) receiving 5  x  104 cells in a total volume of 1.5 ml. 
Cos-7 cells were grown in DME medium supplemented with 10% FCS. 
Transfections were performed with PR expression vector using the calcium 
phosphate precipitate method, as previously  described (13). 
Antibodies 
Two monoclonal mouse antirabbit progesterone receptor designated Mi60 
(IgG2a) (24) and Let 126 (IgG0 (26) were used.  They were diluted to a 
final concentration of 12 #g/ml IgG for immunofluorescence  studies,  The 
characteristics of these antibodies have been extensively described (29, 30). 
They recognize a region on PR separate from the ligand ami DNA-binding 
domains (26). 
The following antibodies directed against the cytoskeleton elements were 
used: (a) a monoclonal mouse antichicken brain B tubulin (dilution 1:300; 
Amersham  International, Amersham, UK) and a monoclonai rat antitubulin 
(dilution 1:20; Biosys, Compi~gne,  France); two polyclonal rabbit anti-sea 
urchin tubulin or antibovine brain tub  ulin (dilution  1:10; Dakopatts,  Gtos- 
trup, Denmark); (b) a polyclonal rabbit  antichicken  actin (dilution 1:10; Bio- 
medical Technologies,  Stoughton, MA); (c) A polyclonal goat antimouse 
fibroblast  vimentin  (dilution 1:40; Miles Laboratories Inc., Naperville, IL). 
Rhodamine phalloidin was also used in this study to label microfilnmeuts. 
The following secondary polyclonal  antibodies were used: (a) a FITC- 
conjugated goat (or rabbi0 anti-mouse IgG (dilution  1:60; Dakopatts);  (b) 
FITC or rhodamine-conjugated  goat anti-rabbit  IgG (dilution 1:40 and 1:80, 
respectively;  Nordic); (c) FFIC or rhodamine-conjugated  rabbit anti-goat 
IgG (dilutions 1:40 and t:80, respectively;  Nordic); (d) biotinylated goat 
anti-rat Ig and rhodnmine-streptavidin  (dilution  1:100; Amersham Interna- 
tional). 
Drug Treatments 
Demecolcine (=N-deacetyl-N-methyl-colchicine, colcemid), nocodazole, 
cytochalasin B  and D,  phalloidin, and acrylamide were  obtained from 
Sigma Chemical Co. (St. Louis, MO). The cell cultures were treated on the 
second to fourth day of subculture.  The following substances were used at 
37~  2-5 #M demecolcine (2-6 h),  10 #M nocodazole  (1-2 h), 20 #M 
cytochalasin B (15 rain-6 h) or 2 #g/nil cytochalasin D (1 h), I0 #m phal- 
loidin (1-3 h), 5 mM acrylamide (4 h) or a mixture of 2/~M demecolcine 
for 6 h and 20 #M cytochalasin  B for 1 h. The cells,  still in the presence 
of the drugs,  were further incubated with progesterone (10  -6 M in DME; 
Sigma Chemical Co.) for 4 h at 37~  Cells were then fixed, processed,  and 
analyzed by indirect  immunofluorescence.  Control experiments consisted of 
cell cultures incubated in the absence of either progesterone  or cytoskele- 
ton-disrupting drugs.  Reversibility of the effect was assessed by incubating 
cells with cytoskeleton-disrupting drugs,  then removing  the drug (2 h to 
overnight),  The cells were lastly incubated in DME plus progesterone for 
4 h. I0 mM sodium azide (Merck) was added for 4 h where indicated. This 
inhibitor was always used with DME supplemented with 6 mM 2-deoxy- 
glucose instead  of glucose,  as previously  described (14). 
Fixation Procedures 
The fixation procedures were used before indirect immunofluorescence  mi- 
croscopy. 
Fixation of Unextracted Cells. The cells were rinsed twice with PBS, 
and treated for 15 min at 20~  as follows: (a) 4 % (wt/vol) paraformaldehyde 
in PBS, pH 7.4; (b) picric-acid paraformaldehyde,  pH 7.4; (c) periodate- 
lysine-paraformaldehyde,  pH 7.4 (30). After fixation, the cells were washed 
twice with PBS and permeabilized with 0.2 % Triton XI00 (Sigma Chemical 
Co.) for 4 min; (d) 0.2%  glutaraldehyde  in PBS comaining 0.2%  Triton 
X100 for 10 rain at 4~  followed by sodium borohydride (3 x  10 rain); (e) 
methanol fixation.  The cells were rinsed twice with PBS, and treated for 
10 rain with methanol at -20~ 
Paraformaidehyde Fixation of Detergent-extracted Cells. To  remove 
soluble proteins the cells were exposed to several concentrations of Triton 
XI00 (0.05-0.5%  in PETS) or of saponine (7.5-75  ￿  10  -3 mg/ml in PBS) 
before fixation.  In other experiments, the ceils were lysed with detergent 
according to the procedure described for the study of the cytoskeletal frame- 
work: the cells were first washed with buffer A (0.1 M Pipes,  pH 6.9 con- 
taining 1 mM EGTA,  2.5 mM GTP, and 4% polyethylene  glycol).  They 
were then incubated for 4  rain at room temperature with the same buffer 
containing 0.2%  Triton (28).  For the visualization of intermediate and 
microftlaments,  the cells were first briefly rinsed with buffer B (10 mM 
Hepes, pH 6.8, containing 100 mM KCI, 3 mM MgC12, 1 mM CaC12, 200 
mM sucrose). They were then treated for 2 rain with buffer B containing 
The Journal of Cell Biology, Volume 119, 1992  338 l~gure 1. Distribution of A638-642 progesterone receptor in the cytoplasm of L cells. Interphase mouse fibroblast cells were stained for 
PR using immunofluorescence and conventional microscopy (a-c) or confocal laser microscopy (d and e). Note the strong fluorescence 
in regions near the nucleus and the additional low, diffuse fluorescence extending toward the cell periphery. Confocal microscopy at high 
magnification shows the appearance of a perinuclear network with outward extensions (e). In d, the selected plane of focus shows either 
a  large perinuclear accumulation of fluorescence or a  thin perinuclear ring, depending on the cell.  Some regions of the cytoplasm are 
nearly devoid of labeling. In c, PR staining is observed by conventional microscopy in Triton-extracted cells (0.05 % for 2 rain). Note the 
clustering of fluorescence around the nucleus and within the cytoplasm after removal of soluble proteins. Similar patches of fluorescence 
were observed using confocal microscopy (not shown).  Bars: (a-d) 20/~m;  (e)  10 gm. 
0.5% Triton and 0.15 rag/nil PMSF (10). The cells were then rinsed in PBS 
and fixed in 4% paraformaldehyde for 15 rain at room temperature. In addi- 
tion to indirect immunotiuorescence,  Triton-permeabilized cells were also 
stained with the immunoperoxidase method (29). 
Indirect Immunofluorescence Staining 
Fixed cells were rinsed three times in PBS and preincubated in goat serum 
diluted 1:40 in PBS. The cells were incubated with mouse Mi60 anti-PR 
antibody (12 gg/mi) for 12 h at 4~  and rinsed three times over a period 
of 20 rain. The cells were then incubated for 60 rain with FITC-conjugated 
secondary antibody (goat anti-mouse IgG), washed three times with PBS, 
and mounted in PBS/glycerol.  Controls were carried out by an identical pro- 
cedure,  except that the primary antibody was replaced by a nonimmune se- 
rum or a PR unrelated mAb. 
Double immunofluorescence  studies were performed on aldehyde  (4% 
paraformaldehyde)  or methanol-fixed cells. For receptor and actin staining, 
the cells were incubated overnight  with a mixture of mouse anti-PR and rab- 
bit antiactin (or rhodamine-eonjugated phalloidin) for 12 h at 4"C. Cells 
were then incubated with a mixture of FITC-conjugated  goat anti-mouse 
IgO and rhodamine-conjugated  goat anti-rabbit  IgG for 1 h at room temper- 
ature. For the simultaneous detection of the receptor and vimentin, the cells 
were successively  incubated with mouse anti-PR, FITC-conjugated  rabbit 
anti-mouse IgG, goat antivimentin and rhodamine-conjugated rabbit anti- 
goat IgG. For the simultaneous detection of receptor and tubulin, the cells 
were successively  incubated under two different conditions, depending on 
which antigen (receptor or tubulin) was first rewealed: (a) mouse anti-PR, 
FITC-conjugated  rabbit anti-mouse IgG, then rat antitubulin, biotinylated 
goat anti-rat IgG and rhodamine-streptavidin; or (b) rat antitubulin, bi- 
otinylated goat anti-rat IgG, rhodamine-streptavidin, then mouse anti-PR 
and FITC-conjugated  rabbit anti-mouse IgG. In these conditions, no cross 
reactivity  or spillover was observed after omitting the antireceptor or any 
Perrot-Applanat et al. Cytoskeleton  and Progesterone Receptor Tra~c  339 Figure 2. Double-labeling  immunofluorescence  with anti-PR and antitubulin  antibodies. Conventional immunofluorescent  microscopy. In- 
terphase cells expressing A638-642 PR were double stained with anti-PR antibody (a) and antitubulin antibody (b). PR does not appear 
to be colocalized along cytoplasmic microtubules. (c and d) Mitotic cells were double stained for PR (c) and tubulin (d).  The mitotic 
apparatus (thin  arrow) and midbodies (thick arrow) well stained with antitubulin antibody are devoid of PR staining. Methanol fixation 
had to be used for these experiments, in order to observe both PR and microtubules staining. Bars, 25 ~m. 
of the antitubulin, antiactin, or antivimentin antibodies. Observations were 
made  on a  Leitz  orthoplan microscope  equipped  with epifluorescence. 
Color and black and white photographs were taken with Fuji 800 ASA or 
Kodak T Max 400 using a 40x  objective. 
Confocal Microscopy 
Confocal laser scanning microscopy was performed using a BioRad MRC- 
600 (BioRad Laboratories,  Palo Alto,  CA), mounted on an Optiphot II 
Nikon microscope equipped with a 60￿  objective (plan apochromatic NA 
1.4). An Argon ion laser adjusted at 488 nm wave length was used for the 
analysis of fiuorescein, and an Helium-Neon ion laser adjusted at 543 ran 
was used for the analysis of rhodamine. The emitted light was separated by 
a dichroic mirror (DIL565); a 540DF30 band pass filter was placed in front 
of the photomultiplier collecting the fluorescein emission, and a EF600LP 
long pass filter was placed in front of the photomultiplier collecting the 
rhodamine emission. The adjustment of the confocal system aUows a field 
depth of "~  /~m. Double fluorescence images were acquired  in two 
passes, fluorescein first, rhodamine second. The emitted signal was digital- 
ized by Kalman filter collection, and each section was scanned eight times. 
Color and black  and white pictures  from screen images were taken on 
Fujichrome 100 and Kodak TMax 100, respectively. 
Results 
Nonrandom Cytoplasmic Distribution ofA638-642 
Progesterone Receptor in Transfected Cells 
A PR mutant (A638-642) which fails to accumulate into the 
nucleus in the absence of hormone has been used to inves- 
tigate  the  cytoplasmic  distribution of PR.  This  mutant is 
characterized by the lack of five amino acids within the con- 
stitutive karyophilic NLS. All other functional properties of 
this mutated  form of PR were preserved  (14). 
Indirect  immunofluorescence,  with  both  conventional 
light microscopy and confocal laser microscopy, and various 
fixation conditions (see Materials and Methods) were used. 
In the absence of hormone, the A638-642 receptor expressed 
in L  cells was always  found in the cytoplasm,  as shown in 
Fig.  1.  Using conventional light microscopy (Fig.  1,  a  and 
b),  immunofluorescence was  very  bright  and  diffuse  in  a 
large perinuclear area.  In the lamellipodes the intensity of 
fluorescence was faint, whereas staining was rather intense 
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munofluorescence with  anti- 
PR (/eft)  and anfitubulin  (right) 
antibodies.  Confc~.al  laser scan- 
ning  microscopy  was  used. 
Serial  optical  sections  were 
obtained at 1-t~m increments. 
The figure shows a series of 
three  optical  0.5-/~m  thick 
transversal  sections  at  4-ttm 
intervals  through  the  whole 
cell. The images were scanned 
in the sequence a-c, i.e., start- 
ing from the top of the cell (a) 
and moving toward the bottom 
(c). Different distributions of 
PR and tubulin are apparent in 
each section. 
in ruffles. Confocal laser microscopy producing 0.5-/~m thick 
optical sections, showed that the perinuclear accumulation 
pattern was  not due to  the increased depth of cytoplasm 
around the nucleus (Fig.  1 d).  Confocal laser microscopy 
also showed a  fluorescence pattern having the appearance 
of a  lattice and  forming a  discontinuous perinuclear ring 
(Fig.  1 e). 
The location of the A638-642 receptor was also studied 
after removing soluble proteins by permeabilization of the 
cells before paraformaldehyde fixation. Cells were first in- 
cubated in conditions that are usually used to analyze Triton- 
insoluble structures of the cytoskeleton (0.2-0.5%  Triton 
X100 for 2  min). In these conditions, nearly all PR mole- 
cules were extracted indicating that most of  the receptor was 
not tightly bound to insoluble cell structures. However, when 
a lower concentration of  Triton X100 (0.05% for 30 s-2 min) 
was used, the perinuclear ring remained visible by either im- 
munofluorescence or the indirect peroxidase method (Fig. 1 
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munofluorescence with  anti- 
PR (/eft) and antivimentin or 
antiactin (right) antibodies. (a 
and b)  The  same cells were 
double  stained  with  anti-PR 
antibody (a) and antivimentin 
(b)  antibodies using conven- 
tional light microscopy. (c and 
d) The same cells were double 
stained with anti-PR (c) and 
antiactin (d) antibodies using 
confocal  laser  microscopy. 
Bars, 25 #m. 
c). Also, after this treatment, confocal laser microscopy de- 
tected patches  of fluorescence within  the  cytoplasm (not 
shown). 
Comparison  between the Distribution of  PR and of 
Cytoskeletal Elements 
The pattern of distribution of the A638-642  receptor de- 
scribed above suggested the possibility that PR molecules 
were interacting with an organized network. The distribution 
of PR was thus compared to that of the three main constitu- 
ents of the cytoskeleton (microtubules, microfilaments, and 
intermediate filaments). 
L  cells with a  flat morphology (i.e.,  well-spread cells) 
were preferentially examined because they provide a large 
area  of cytoplasm that is  optimal for the visualization of 
cytoskeleton elements.  Antitubulin and antivimentin anti- 
bodies stained wavy fibers extending throughout the cyto- 
plasm. Antitubulin labeling (Fig. 2 b) radiated from a focal 
point near the nucleus (centrosome) towards the cell periph- 
ery through all  regions  of the cytoplasm with  no special 
aggregation.  Antivimentin staining  (see Fig.  4  b)  showed 
marked perinuclear accumulation with filaments extending 
both to the nucleus and the cell periphery. Actin was local- 
ized to thin filaments (microfilaments) and to the periphery 
of  the cell at the level of submembranous domains and ruffles 
(see Fig. 7 e). The cells were also characterized by a diffuse 
perinuclear stain for actin and by the presence of few stress 
fibers (as  shown with  antiactin antibodies  and  with phal- 
loidin). Therefore, the pattern of PR immunostaining did not 
resemble  the  filamentous  staining  pattern  observed  for 
microtubules or intermediate filaments. As well, actin distri- 
bution in the cell periphery was clearly different from that 
of PR. Around the nucleus, the very dense immunolabeling 
made  comparison  difficult;  however,  the  width  of  the 
perinuclear accumulation of PR seemed greater than that ob- 
served for actin. 
To compare more precisely the distribution of PR with that 
of the  cytoskeletal elements,  double-labeling  experiments 
were also performed using both conventional and confocal 
microscopy. The same  cells were  treated with  antibodies 
against PR on one hand and tubulin, actin, or vimentin on 
the  other  hand.  Varying  experimental  conditions  were 
tested, such as the use of methanol or aldehyde fxation. In 
some experiments, detergents were also used before fixation 
to remove soluble proteins. The staining patterns of PR and 
of  the various cytoskeletal elements were different using both 
conventional  and  confocal laser  microscopy  (Figs.  2-4). 
This was especially visible in the cell periphery (i.e., the 
thinner part of the cells) where microtubules, intermediate 
filaments,  or microfilaments were  not decorated with PR 
(Figs.  2,  a  and b  and 4).  The centrosomal region did not 
show accumulation of PR. In contrast, a strong fluorescence 
was observed in the perinuclear area with both anti-PR anti- 
bodies and anticytoskeletal antibodies. This led to a lack of 
resolution of cytoskeletal elements which did not allow for 
the determination of whether fluorescein-decorated PR was 
associated with some cytoskeleton elements. With confocal 
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A638-642  progesterone  receptor.  Immuno- 
fluorescent receptor is cytoplasmic in the ab- 
sence of hormone (a), but is shifted into the 
nucleus  under  progesterone  administration 
(10  -6 M, 4 h) (b). Bar, 25/zm. 
microscopy (Figs. 3 and 4, c and d), the different networks 
were more clearly contrasted in the perinuclear region and 
appeared non coincident with PR staining. At high magnifi- 
cation, most of the PR fluorescence appeared as irregular 
large patches  located between microtubules,  intermediate 
filaments and actin microfilaments (not shown). In permeabil- 
ized cells, the persistent cytoplasmic fluorescent PR patches 
and the discontinuous PR perinuclear ring did not decorate 
cytoskeleton scaffolds (not shown). 
Mitotic fibroblasts were also examined. The staining for 
PR was stronger in mitotic cells when compared to the sur- 
rounding interphase cells. PR fluorescence was homogene- 
ously distributed throughout the cells. However, PR fluores- 
cence  was  not  present  in  the  chromosome region  or  on 
structures such as the mitotic spindle or midbodies which are 
known to contain tightly packed microtubules (Fig. 2, c and 
d).  This  was  confirmed by confocal laser microscopy in 
different sections of mitotic cells at all stages of mitosis (not 
shown). 
In conclusion, results obtained in the various experiments 
indicated a nonrandom distribution of A638-642 PR in the 
cytoplasm, suggesting its interaction with some cytoplasmic 
constituent(s). However, the majority of PR was soluble or 
easily extractable and its distribution was not similar to that 
of microtubules, microfilaments, or intermediate filaments. 
These observations could not exclude the possibility that a 
small fraction of PR molecules interacted transiently with 
the cytoskeleton, being in equilibrium with a large pool of 
soluble PR. Such an interaction could have preceded the in- 
teraction of  the receptor with components of  the nuclear pore 
complex in the process of translocation into the nucleus. If 
this  was  the  case,  nuclear accumulation of PR  should be 
blocked by agents known to disrupt the cytoskeleton. 
Nuclear Accumulation ofz1638-642 
Progesterone Receptor in the Presence of 
Cytoskeleton-disrupting Drugs 
L  cells expressing the A638-642  PR were incubated with 
progesterone 10  -6 M  for time intervals varying between 30 
min and 6 h. A 4-h time period was necessary to obtain max- 
imal nuclear translocation of PR from the cytoplasm to the 
nucleus (Fig. 5). We then asked whether the receptor would 
localize  in  the  nucleus  of  cells  containing  a  disrupted 
cytoskeleton. 
Nocodazole, demecolcine (colcemid), and cytochalasin B 
were  used  to  disrupt  the  microtubular,  intermediate  fila- 
ment, and microfilament networks. These drugs have well- 
documented effects on the three major cellular cytoskeleton 
networks (7,  16, 23,  39, 42). However, it was  necessary to 
determine optimal conditions for the disruption of these net- 
works in mouse L  fibroblasts (not shown). 
After 1 h of treatment with nocodazole (10 #M), the over- 
all cell shape became more rounded.  Staining  for tubulin 
showed  that  the  microtubular  network  had  disappeared 
(compare Figs. 6 b and 2 b). A small coiling of vimentin fila- 
ments was still observed around the nucleus. Staining for PR 
showed that the A638-642 PR was cytoplasmic as in control 
cells incubated in the absence of nocodazole (Fig. 6 a). After 
addition of hormone, the time course of nuclear transloca- 
tion was not changed in the nocodazole-treated cells (Fig. 6 
c). All morphological changes induced by the treatment with 
nocodazole were reversible after changing the cells to a nor- 
mal medium for 2 h (Fig. 6 d). The nuclear staining of PR 
was unchanged in these conditions. 
On treatment with demecolcine (2/zM for 6 h), the cells 
were rounded and the fibrillar aspect of microtubules was no 
longer observed, giving a diffuse pattern of staining with an- 
titubulin antibodies. The vimentin containing filaments ap- 
peared clumped into  thicker bundles  and  took up  coiled 
forms. An intense ring of staining was present around the nu- 
cleus (Fig. 6f). Pretreatment with demecolcine (2-10 h) did 
not alter the penetration of PR into the nucleus in the pres- 
ence of progesterone (Fig.  6 e). 
Treatment of the fibroblasts with cytochalasin B at 20 #M 
induced in 30 min a typical arborization pattern, exhibiting 
total disruption of the actin-containing microfilaments and 
bulging of the nucleus. The same aspect was observed after 
6 h of drug treatment (Fig.  7 c). The filamentous network 
of microtubules and intermediate filaments was less marked 
but immunostaining with antitubulin and antivimentin anti- 
bodies was observed in the center of the cells and extending 
into the various projections. After addition of progesterone, 
the cytochalasin B-treated ceils (30 min to  1 h) exhibited 
also a nuclear localization of A638-642 PR, indicating that 
cytochalasin B did not prevent the nuclear accumulation of 
the receptor (Fig. 7, a and b). Similar results were obtained 
with cytochalasin D  (not shown). This translocation of PR 
from the cytoplasm into the nucleus was  also observed in 
cells exposed for long periods of time to cytochalasin (up to 
18 h). The removal of the drug and the subsequent incubation 
of the ceils in a normal medium for 3 h resulted in the main- 
tenance of the nuclear PR staining and a gradual restoration 
of the typical pattern of staining observed for microfilaments 
(Fig. 7, d and e). Phalloidin, which is known to stabilize ac- 
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642 progesterone receptor in the presence of  drugs 
disrupting  microtubule  or  intermediate  filament 
networks. L cells were treated with nocodazole (10 
/~M,  1 h) or demecolcine  (2 t~M, 2 h),  then in- 
cubated for 4 h either with a mixture of proges- 
terone  (10  -6 M) and nocodazole or demecolcine, 
or with the drug alone (nocodazole or demecol- 
cine).  A  control  experiment  was  performed  in 
which the cells were returned for 2 h to a medium 
without nocodazole or demecolcine. (a and c) Im- 
munofluorescent  PR  in  nocodazole-treated  cells 
either in the absence (a) or in the presence (c) of 
hormone. (b) Immunofluorescent tubulin in noco- 
dazole-treated cells. (d) Immunofluorescent tubu- 
lin in cells previously treated by nocodazole and 
subsequently cultured for 2 h in the absence of the 
drug.  (e) Immunofluorescent PR in demecolcine- 
treated cells in the presence of hormone.  (f) Im- 
munofluorescent vimentin in demecolcine-treated 
cells. Bar, 25 #m. 
tin rnicrofilaments (6), also did not prevent nuclear translo- 
cation of A638-642 PR receptor (Fig. 7, fand g). Treatment 
with a mixture of both demecolcine and cytochalasin B (2/~M 
for 6 h  and 20 #M for the last hour,  respectively) resulted 
in the disruption of both microtubules and microfilaments 
and in the disorganization of intermediate filaments.  Even 
the cells lacking all three cytoskeleton networks could effi- 
ciently accumulate PR in their nuclei in the presence of hor- 
mone (Fig.  8). 
L cells were also treated with acrylamide (5 mM, 4 h) (8) 
to disorganize the intermediate filament network resulting in 
the formation of coiled bundles and of a  perinuclear ring. 
Again,  the  A638-642  receptor was normally translocated 
from the cytoplasm into the nucleus of the cells after pro- 
gesterone treatment (not shown). 
Nuclear Accumulation  of l~ld-type 
Progesterone Receptor in the Presence of 
Cytoskeleton-disrupting  Drugs 
Because it might have been argued that the translocation of 
A638-642 mutant receptor represents a special case, we also 
examined whether the wild type PR could find its way into 
the  nucleus  of cells  containing  a  disrupted  cytoskeleton. 
Ceils were transfected with an expression vector encoding 
the wild type PR.  The receptor was nuclear but  could be 
transferred into the cytoplasm using sodium azide, an inhibi- 
tor of energy synthesis,  as previously described  (14).  The 
cells were then incubated  in  the presence (or absence) of 
cytochalasin  or  nocodazole-containing  medium,  and  then 
returned to azide-free medium. As shown in Fig. 9, the wild 
type PR  which  was mainly observed in  the  cytoplasm in 
energy-depleted cells, was translocated to the nucleus in cyto- 
chalasin or nocodazole-treated cells,  as in control cells. 
Discussion 
The progesterone receptor has been shown to reside in the 
nucleus irrespective of the presence or absence of hormone 
(29).  Recent studies have shown that this cellular distribu- 
tion actually reflects a dynamic situation: the receptor con- 
The Journal of Cell Biology, Volume 119, 1992  344 Figure 7. Hormone-induced  translocation  of the A638-642 progesterone  receptor in the presence of drugs which disrupt or stabilize the 
microfilament network. L cells were treated with cytochalasin (20 #M for 1 h) or phalloidin (10 #M for 1 h), then incubated for 4 h either 
with a mixture of progesterone  (10  -6 M) and the drug (cytochalasin or phalloidin),  or with the drug alone. A control experiment was per- 
formed in which the cells were returned for 2 h to a medium without cytochalasin or phalloidin.  (a and b) Immunofluorescent PR in cyto- 
chalasin-treated cells, either in the absence (a) or in the presence (b) of  hormone. (c) Actin pattern in cytochalasin-treated cells. (d) Immuno- 
fluorescent PR in cells previously treated by cytochalasin and subsequently cultured for 2 h in the absence of the drug. (e) Actin staining 
in the same conditions as in d. Note the gradual restoration  of the actin network.  (fand g) Immunofluorescent PR in phalloidin-treated 
cells,  either  in the absence  (f) or in the presence  (g) of hormone.  Bar, 25/~m. 
stantly diffusing out of the nucleus and being actively reim- 
ported into the nucleus (14). However, the cellular route for 
the translocation of the progesterone receptor from the cyto- 
plasm into the nucleus is not understood, as it is the case for 
all the other steroid hormone receptors. In the case of the 
GR, it has been hypothesized that the receptor was interact- 
ing with elements of the cytoskeleton and that such interac- 
tions were guiding its movements in the cell (2, 27, 33). We 
have tested this  hypothesis using  the  PR  and  studying  its 
translocation into the nucleus after disruption of the various 
cytoskeletal networks. 
The studies were performed with L cells permanently ex- 
pressing a cytoplasmic form of the receptor (mutant A638- 
642) lacking the constitutive NLS (13).  This receptor form 
can be shifted into the nucleus by administration of hormone 
through the unmasking of a second karyophilic signal located 
in the region of the  second zinc finger.  To investigate this 
translocation  in cells containing  a  disrupted  cytoskeleton, 
we used nocodazole, demecolcine, and cytochalasin, which 
have well documented deleterious effects on the cytoskeleton 
networks (7, 16, 23, 39, 42): incubation of cells with nocoda- 
zole caused a selective disruption of the microtubules; long 
treatment (>6 h) with demecolcine resulted in the disappear- 
ance of the microtubules and the collapse of the intermediate 
Perrot-Applanat et al.  Cytoskeleton and Progesterone Receptor Traffic  345 Figure  8.  Hormone-induced 
translocation  of  the  A638- 
642 progesterone  receptor in 
the presence  of drugs  which 
disrupt  all three cytoskeletal 
networks. L ceils were treated 
with a mixture of  demecolcine 
(2/~M  for 6 h) and cytochal- 
asinB (1 h), then incubated for 
4  h either  with  a mixture  of 
progesterone,  demecoleine, 
and cytochalasin,  or with the 
mixture of cytochalasin  and 
demecolcine.  Nuclear PR immunostaining  is shown in cytocha- 
lasin-demecolcine-treated  cells that have been incubated with pro- 
gesterone. Bar, 25 t~m. 
filaments. Cytochalasin B  treatment resulted in the disrup- 
tion of the actin-containing  microfilaments. Moreover, the 
combination of demecolcine and cytochalasin resulted in the 
disruption of all three of the cytoskeleton networks. What- 
ever the drug used,  the penetration of PR into the nucleus 
after  incubation  with  progesterone  was  not  prevented by 
these  drugs.  Control  experiments  indicated  that  the  drug 
treatments by themselves did not result in the nuclear trans- 
location of the A638-642 receptor. In addition, these effects 
on the cytoskeleton were reversible since the removal of the 
drugs and subsequent incubation of the cells in normal cul- 
ture medium resulted in a gradual restoration of the three 
cytoskeleton networks, as seen by indirect immunofluores- 
cence. 
The possibility that the distribution of A638-642 receptor 
could be different from that of the  wild type PR  in cyto- 
skeleton-disrupted cells, was also investigated by blockage 
of the energy-dependent nuclear accumulation of wild type 
PR by sodium azide which induces an efflux of PR from the 
nucleus (14). PR reaccumulated within the nucleus when so- 
dium azide was removed, even in the presence of cytochala- 
sin and nocodazole. This indicates that translocation of the 
wild type receptor from the cytoplasm into the nucleus is not 
dependent on the integrity of the cytoskeleton. 
We have obtained additional evidence against involvement 
of the cytoskeleton in the cytoplasmic traffic of the receptor 
using colocalization experiments performed at the light mi- 
croscope  level.  Immunofluorescence  microscopy  showed 
distinct  distributions  of the  A638-642  PR  and  of micro- 
tubule, intermediate filament, and microfilament networks. 
This result was obtained in various fixation conditions, using 
both conventional light microscopy and confocal laser mi- 
Figure 9. Nuclear accumulation of  wild-type PR in the presence of  cytoskeleton-disrupting drugs. Cos-7 cells were transfected with wild-type 
PR as previously described  (17). The cells were treated with sodium azide (10 ~M) for 3 h. The incubation was continued for 1 h in the 
presence of sodium azide and in the presence or absence of cytoskeleton-disrupting  drugs (nocodazole [20 ~M] or cytochalasin [10 ~M]). 
Finally, sodium azide was removed and the cells were further incubated with cytochalasin or nocodazole for 4 h. (a) Immunofluorescent 
PR is nuclear in control Cos-7 cells (nontreated by drugs).  (b) Immunofluorescent PR has moved into the cytoplasm in Cos-7 cells treated 
for 4 h by sodium azide. (c) PR has been shifted into the cytoplasm by azide treatment for 4 h (see b). Then, azide was removed and the 
cells were cultured for 4 h in DME. The receptor is seen in the nucleus.  (d) PR has been shifted into the cytoplasm by azide treatment 
for 4 h (see b). Cytochalasin was added for 1 h before removing azide and remained present for 3 h after azide was withdrawn. The receptor 
has returned  into the nucleus.  (e) The same as in c, except that nocodazole was used instead of cytochalasin.  Bar, 25 ~m. 
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and microtubules in both interphasic and mitotic L cells. Ki- 
netic analysis of  the hormone-dependent translocation of this 
receptor towards the nucleus showed that the distribution of 
PR in the cytoplasm was not changed during this process 
(our unpublished data).  In the case of the glucocorticoid 
receptor, interactions of receptor with microtubules in hu- 
man gingival fibroblasts (2) and with actin in hepatoma cells 
(27)  were observed by immunocytochemical methods (2) 
and by subcellular fractionation (27).  The distribution of 
hsp90 has also been studied, since this protein is associated 
with steroid hormone receptors (5, 34, 37, 38, 41). Interac- 
tions between hspg0 and tubulin (33, 36), or hspg0 and actin 
(20)  have recently been reported.  However,  at present, no 
studies with cytoskeleton-disrupting  drugs have been used to 
analyze the cellular traffic of steroid receptors. The diverg- 
ing observations on the cytoplasmic distribution of GR (2, 
44) as compared to PR (see above) may be due to differences 
of receptor species or of cell types. The experimental condi- 
tions and the specificity of the antibodies may also be of ma- 
jor influence. For instance, in the present study the use of 
a polyclonal antibody (Dakopatts)  (2)  led to a  nonspecific 
staining which was not observed with highly specific mono- 
clonal antitubulin antibodies. Moreover, mixing of primary 
(anti-PR and antitubulin) or secondary antibodies was also 
observed to produce artefacts. 
Most PR molecules were released from cells that had been 
permeabilized with detergent before fixation, indicating that 
they are not tightly bound to any intracellular structure. The 
receptor-associated protein hsp90 has also been shown to be 
extracted with 0.5%  NP-40 in chicken embryo fibroblasts 
(5). After permeabilization of the cell, however, a small but 
detectable level of PR was retained, especially around the 
nuclear envelope, suggesting an interaction with an insoluble 
structure.  However,  it  proved  impossible to  identify this 
structure at the light microscopic level, even by confocal la- 
ser microscopy. Thus, several pools of PR may coexist in the 
cells including soluble PR and PR loosely complexed with 
some cytoplasmic structure(s).  Further studies at the elec- 
tron microscope level  using gold-labeled reagents will be 
necessary to analyze the distribution of these structures in 
relation to that of  the receptor. Finally, the present study can- 
not exclude a transient association of PR with cytoskeletal 
proteins. However, it is clear that the intracellular transport 
of the receptor towards the nucleus appears operable in cells 
lacking an organized cytoskeleton. 
Nuclear protein import is a selective process.  Proteins des- 
tined for the nucleus contain NLSs (18, 22, 40). Karyophilic 
signals of steroid receptors (13, 31-32) are similar to those 
present in SV-40 large T  antigen, nucleoplasmin, etc.  Ex- 
perimental evidence for the existence of transport receptors 
for NLS-containing proteins has been provided by several 
laboratories (1, 4,  reviewed in 40).  These proteins, called 
NLS-binding proteins, are located in the cytoplasm, on the 
nuclear envelope, and/or at the nuclear pore complex. After 
binding at the pore complex, proteins are translocated through 
the pore into the nucleus in an energy requiring step.  The 
interaction of GR with a protein of the nuclear envelope has 
also recently been identified by cross-linking experiments 
(21). However,  few studies have shed light on the nature of 
the structures involved in the transport of nuclear proteins 
and receptors from the cytoplasm into the nucleus. Hypothe- 
ses have been proposed that steroid receptor movement to- 
wards the nucleus involves cytoskeleton-scaffold  supporting 
protein transfer (2,  33).  More generally, few studies have 
analyzed the role of the cytoskeleton in the process of nu- 
clear import (35, 42).  However,  it has been shown that the 
nuclear translocation of the 72-kD hsp and of the adenovirus 
E1A protein occurs after the disorganization of the three ma- 
jor cytoskeletal systems (42). 
In  conclusion,  we  have  not been  able  to  observe  any 
colocalization of the progesterone receptor with the various 
cytoskeletal elements. Disruption of these networks had no 
effect on the translocation of the receptor into the nucleus. 
The NLSs and their interaction with the elements of the nu- 
clear pore seem to be the major determinants of receptor 
traffic in the cells. 
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